BPIA Secures Plant Biostimulant Priorities in House Farm Bill
BPIA applauds the House Committee on Agriculture for unveiling its full 2024 Farm Bill text and including regulatory reforms inspired by the Plant Biostimulant Act, H.R. 1472.
Read MoreBPIA applauds the House Committee on Agriculture for unveiling its full 2024 Farm Bill text and including regulatory reforms inspired by the Plant Biostimulant Act, H.R. 1472.
Read MoreBPIA applauds the House and Senate Agriculture Committees for advancing the 2024 Farm Bill by unveiling their respective frameworks. This legislation signifies a significant stride towards bolstering our agricultural landscape, prioritizing the needs of frontline growers and consumers, and the sustainable stewardship of our natural resources.
Read MoreBPIA submitted comments to the National Organic Standards Board to help rectify the USDA organic regulations’ references to the outdated EPA inert ingredient Lists 3 and 4 and improve the policies and procedures for establishing allowable pesticide inert ingredients for use in organic crop and livestock production.
Read MoreView presentations from the BPIA 2024 Annual Meeting here.
Read MoreBPIA and other stakeholders submitted a proposal to the CFIA to permit registrants to change suppliers of certain ingredients without submitting an Ingredient Source Change Inquiry.
Read MoreBPIA filed comments regarding an ANPR concerning the EPA’s approach to regulation of seeds treated with a pesticide registered under FIFRA.
Read MorePlease join us for the BPIA 2024 Annual Meeting in Washington, DC on March 26-27, 2024!
Read MoreBPIA submitted comments to the National Organic Standards Board regarding allowable biological pesticide inert ingredients for use in organic crop production.
Read MoreBPIA filed comments regarding Pesticide Registration Improvement Act Bilingual Labeling Requirements.
Read MoreBPIA submitted comments regarding policy for addressing missing/incomplete data during the scientific evaluation process
Read MoreBPIA filed comments regarding EPA’s Draft Guidance Regarding Endangered Species Act Consideration.
Read MoreBPIA submits comments regarding Draft Guidance on Field Trial Requirements for Efficacy and Phytotoxicity.
Read MoreBPIA submits comments regarding proposed changes to the California Pesticide Registration Branch workload assignments.
Read MoreBPIA applauds the bipartisan introduction of the Plant Biostimulant Act of 2023 in the Senate and the U.S. House of Representatives (H.R. 1472). BPIA thanks Senators Mike Braun (R-IN) and Alex Padilla (D-CA) as well as Congressmen Jimmy Panetta (D-CA) and Jim Baird (R-IN) for sponsoring the bill.
Read MoreBPIA and other industry stakeholders suggested the PMRA consider reviewing and modernizing regulations for dual property products containing crop protection and crop health improvement properties to enable registration of these products under single label.
Read MoreView presentations from the BPIA 2023 Annual Meeting here.
Read MoreBPIA hosted a virtual listening session regarding biostimulants to support the National Biotechnology and Biomanufacturing Initiative.
Read MoreBPIA provided input to the White House Office of Science and Technology Policy regarding the Coordinated Framework to accelerate biotechnology innovation and grow America’s bioeconomy.
Read MoreBPIA provided a response to the PMRA’s request for comments regarding PRO2022-01 Pre-Consultation – Proposed Regulatory Amendments to the Pest Control Products Regulations
Read MoreBPIA filed comments regarding ANPR concerning USDA-AMS-NOP’s request for comments on how to rectify the USDA organic regulations’ references to outdated EPA policy on inert ingredients used in pesticide products.
Read More